BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29473340)

  • 1. A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
    Wang M; Gao Y; Feng H; Warner E; An M; Jia J; Chen S; Fang M; Ji J; Gu X; Gao C
    Cancer Med; 2018 Mar; 7(3):646-654. PubMed ID: 29473340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
    Chen L; Zeng F; Yao L; Fang T; Liao M; Long J; Xiao L; Deng G
    Cancer Med; 2020 Feb; 9(4):1451-1461. PubMed ID: 31903730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative study of intrahepatic cholangiocarcinoma and hepatocellular carcinoma with reference to clinical features and prognosis].
    Hu JY; Zhou HB; Liu WD; Zhang J; Hu HP; Liu J
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):511-515. PubMed ID: 31357776
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum N-glycan fingerprint helps to discriminate intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
    Huang C; Xu X; Wang M; Xiao X; Cheng C; Ji J; Fang M; Gao C
    Electrophoresis; 2021 Jun; 42(11):1187-1195. PubMed ID: 33570803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 6. Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
    Zhang X; Huang WJ; Zhang ML; Wang W; Niu Y; Wang RT; Liu ZY
    BMC Gastroenterol; 2022 Jun; 22(1):288. PubMed ID: 35668355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic features, treatment, survival, and prognostic factors of combined hepatocellular and cholangiocarcinoma: A nomogram development based on SEER database and validation in multicenter study.
    Zhou YW; Li QF; Chen YY; Wang K; Pu D; Chen XR; Li CH; Jiang L; Wang Y; Li Q; Yang Y; Gou HF; Bi F; Liu JY; Chen Y; Qiu M
    Eur J Surg Oncol; 2022 Jul; 48(7):1559-1566. PubMed ID: 35115213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
    Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
    World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma.
    Yamamoto M; Ariizumi S; Otsubo T; Katsuragawa H; Katagiri S; Nakano M; Takasaki K
    J Surg Oncol; 2004 Aug; 87(2):80-3; discussion 83-4. PubMed ID: 15282700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
    Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
    J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram based on Sonazoid contrast-enhanced ultrasound to differentiate intrahepatic cholangiocarcinoma and poorly differentiated hepatocellular carcinoma: a prospective multicenter study.
    Wang S; Yao J; Li K; Yang H; Lu S; He G; Wu W; Cheng W; Jiang T; Ding H; Jing X; Yan Y; Liu F; Yu J; Han Z; Cheng Z; Tan S; Li X; Dou J; Li Y; Qi E; Zhang Y; Liang P; Yu X
    Abdom Radiol (NY); 2023 Oct; 48(10):3101-3113. PubMed ID: 37436451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nomogram to predict lymph node metastasis before resection in intrahepatic cholangiocarcinoma.
    Meng ZW; Lin XQ; Zhu JH; Han SH; Chen YL
    J Surg Res; 2018 Jun; 226():56-63. PubMed ID: 29661289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers.
    Wakizaka K; Yokoo H; Kamiyama T; Ohira M; Kato K; Fujii Y; Sugiyama K; Okada N; Ohata T; Nagatsu A; Shimada S; Orimo T; Kamachi H; Taketomi A
    J Gastroenterol Hepatol; 2019 Jun; 34(6):1074-1080. PubMed ID: 30462849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation biomarkers for diagnosis of primary liver cancer and distinguishing hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
    Bai Y; Tong W; Xie F; Zhu L; Wu H; Shi R; Wang L; Yang L; Liu Z; Miao F; Zhao Q; Zhang Y
    Aging (Albany NY); 2021 Jul; 13(13):17592-17606. PubMed ID: 34237708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
    J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma.
    Zhou XD; Tang ZY; Fan J; Zhou J; Wu ZQ; Qin LX; Ma ZC; Sun HC; Qiu SJ; Yu Y; Ren N; Ye QH; Wang L; Ye SL
    J Cancer Res Clin Oncol; 2009 Aug; 135(8):1073-80. PubMed ID: 19294418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A case report and review of the literature.
    Qu MM; Zhu YH; Li YX; Li ZF; Li JK; Xu YS; Shrestha M; Lei JQ
    Medicine (Baltimore); 2021 Nov; 100(46):e27349. PubMed ID: 34797273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Efficient Nomogram for Discriminating Intrahepatic Cholangiocarcinoma From Hepatocellular Carcinoma: A Retrospective Study.
    Si YQ; Wang XQ; Pan CC; Wang Y; Lu ZM
    Front Oncol; 2022; 12():833999. PubMed ID: 35480111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?
    Zhou Q; Cai H; Xu MH; Ye Y; Li XL; Shi GM; Huang C; Zhu XD; Cai JB; Zhou J; Fan J; Ji Y; Sun HC; Shen YH
    Hepatobiliary Pancreat Dis Int; 2021 Feb; 20(1):13-20. PubMed ID: 33160852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic nomograms for newly diagnosed intrahepatic cholangiocarcinoma with brain metastasis: A population-based analysis.
    Liu Z; Yi J; Yang J; Zhang X; Wang L; Liu S
    Exp Biol Med (Maywood); 2022 Sep; 247(18):1657-1669. PubMed ID: 35946168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.